Trends in antimicrobial susceptibility of Streptococcus pneumoniae in the Tohoku district of Japan: a longitudinal analysis from 1998 to 2007.

@article{Suzuki2010TrendsIA,
  title={Trends in antimicrobial susceptibility of Streptococcus pneumoniae in the Tohoku district of Japan: a longitudinal analysis from 1998 to 2007.},
  author={Kazumasa Suzuki and K. Nishimaki and K. Okuyama and T. Katoh and M. Yasujima and J. Chihara and A. Suwabe and Y. Shibata and C. Takahashi and H. Takeda and S. Ida and M. Kaku and A. Watanabe and T. Nukiwa and K. Niitsuma and K. Kanemitsu and M. Takayanagi and I. Ohno},
  journal={The Tohoku journal of experimental medicine},
  year={2010},
  volume={220 1},
  pages={
          47-57
        }
}
Streptococcus pneumoniae is a common cause of respiratory tract infections (RTIs). The prevalence of Streptococcus pneumoniae strains with reduced susceptibility to antimicrobial agents has dramatically increased worldwide. Susceptibility to nine antimicrobial agents and serotypes were determined among 1,644 Streptococcus pneumoniae strains isolated from patients with RTIs in the Tohoku district of Japan from October to December every year from 1998 to 2007. The prevalence of penicillin G… Expand
9 Citations
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program.
TLDR
The results from the current study confirmed the regional variations in antimicrobial susceptibility of major CARTI pathogens and provided some choices for the treatment of these organisms. Expand
Penicillin-Resistant trend of Streptococcus pneumoniae in Asia: A systematic review
TLDR
Investigation of the changing trend of penicillin-resistant S. pneumoniae (PRSP) in Asia over a 20 years period found variations in susceptibility rates among different centers in each country varied widely. Expand
Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.
TLDR
These results from the CARTIPS study have confirmed some significant regional differences in the antimicrobial susceptibilities of S. pneumoniae, MSSA, K. influenzae and Streptococcus spp. Expand
Novel synthetic antimicrobial peptides with In-Vivo and In-Vitro activity against Streptococcus Pneumoniae / Le Cheng Foh
TLDR
It is demonstrated that AMPs represent the promising new generation antibiotics as standalone therapeutics or in combination with conventional antibiotics. Expand
Nationwide survey of Streptococcus pneumoniae drug resistance in the pediatric field in Japan
TLDR
The Drug‐Resistant Pathogen Surveillance Group in Pediatric Infectious Disease conducted a nationwide surveillance of S. pneumoniae in 2000–2001, 2004, 2007, 2010 and 2012, and investigated changes in drug resistance. Expand
Serotype Replacement in Adult Pneumococcal Pneumonia after the Introduction of Seven-Valent Pneumococcal Conjugate Vaccines for Children in Japan: a Systematic Literature Review and Pooled Data Analysis.
TLDR
Serotype replacement occurred in adult cases of pneumococcal pneumonia following vaccination of children with PCV7 in Japan, and nationwide surveillance is warranted to investigate serotype replacement in the post-PCV13 phase. Expand
Update on the clinical utility and optimal use of cefditoren
TLDR
It is concluded that cefditoren is an adequate option for the treatment of mild-to-moderate community-acquired respiratory infections, especially in geographical areas with a reported prevalence of phenotypes exhibiting nonsusceptibility to common oral antibiotics. Expand
Current Trend in Pneumococcal Serotype Distribution in Asia
TLDR
Recent insights into the regulation of NK cell function and the T cell-mediated immune system as tumor immune surveillance are summarized, first attempts to exploit NK cell activation to improve immunity to tumors are attempted. Expand

References

SHOWING 1-10 OF 53 REFERENCES
Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004).
TLDR
Telithromycin was highly active against all three pathogens examined throughout the study and accounted for the most erythromycin-resistant isolates in each study year. Expand
Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
TLDR
The penicillin-resistant S. pneumoniae population has changed; most isolates are now closely related to 2 Pneumococcal Molecular Epidemiology Network clones that increased in prevalence from 1999-2000 to 2004-2005. Expand
Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1–3 (1999–2002)
  • M. Inoue, K. Kaneko, +11 authors Y. Hirakata
  • Biology, Medicine
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
  • 2006
TLDR
Antimicrobial resistance among isolates of Streptococcus pneumoniae, Streptoco-ccus pyogenes, Haemophilus influenzae, and Moraxella catarrhalis collected in Japan during years 1–3 of the PROTEKT surveillance study is presented. Expand
Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from 1994 to 2002.
TLDR
Streptococcus pneumoniae and Haemophilus influenzae exhibited stable and high rates of susceptibility to FQ over the period examined and no FQ resistance in clinical isolates of Salmonella spp. Expand
Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006.
TLDR
Findings indicate a high level of penicillin resistance and continued usefulness of amoxicillin/clavulanate in S. pneumoniae and H. influenzae and a need for continued surveillance. Expand
Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe.
TLDR
The results indicate that appropriately dosed beta-lactams for empirical therapy are still the treatment of choice, and that macrolides should be used with prudence. Expand
Rapid Increase of Pneumococcal Resistance to β‐Lactam and Other Antibiotics in Isolates from the Respiratory Tract (Nagasaki, Japan: 1975–1994)
TLDR
The susceptibility of 101 pneumococcal isolates from the respiratory tract during 1991–1994 was examined and compared with the susceptibility of isolates over the period of 1975–1990, suggesting that anti‐pneumococcal antibiotics should be carefully chosen on the basis of susceptibility tests. Expand
Antimicrobial Resistance among Clinical Isolates ofStreptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995
TLDR
Overall, antimicrobial resistance was highest among middle ear fluid and sinus isolates of S. pneumoniae; lowest resistance rates were noted with isolates from cerebrospinal fluid and blood. Expand
Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study.
  • J. H. Song, N. Lee, +16 authors C. Pai
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1999
TLDR
The possible introduction and spread of international epidemic clones into Asian countries and the increasing problems of pneumococcal drug resistance in Asian countries for the first time are suggested. Expand
Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?
  • G. Doern, S. Richter, +4 authors S. Beekmann
  • Medicine, Biology
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2005
TLDR
It appears that, as fluoroquinolone resistance emerges among S. pneumoniae in the United States, resistance to other antimicrobial classes is becoming less common and rates of resistance to beta -lactams, macrolides, tetracyclines, TMP-SMX, and multiple drugs have either plateaued or have begun to decrease. Expand
...
1
2
3
4
5
...